Cargando…
TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter
BACKGROUND: As a lipid metabolic disorder, non-alcoholic fatty liver disease (NAFLD) is an important cause of cirrhosis and hepatocellular carcinoma, with no effective drug up to date. Previous studies have demonstrated increased methylation levels of key genes in NAFLD, suggesting that hydroxymethy...
Autores principales: | Wang, Jingjie, Zhang, Yitong, Zhuo, Qin, Tseng, Yujen, Wang, Jiucun, Ma, Yanyun, Zhang, Jun, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304222/ https://www.ncbi.nlm.nih.gov/pubmed/32577122 http://dx.doi.org/10.1186/s12986-020-00466-8 |
Ejemplares similares
-
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
por: Régnier, Marion, et al.
Publicado: (2020) -
TET2 is recruited by CREB to promote Cebpb, Cebpa, and Pparg transcription by facilitating hydroxymethylation during adipocyte differentiation
por: Liu, Yunjia, et al.
Publicado: (2023) -
TET Upregulation Leads to 5-Hydroxymethylation Enrichment in Hepatoblastoma
por: Rivas, Maria Prates, et al.
Publicado: (2019) -
The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
por: Brągiel-Pieczonka, Aneta, et al.
Publicado: (2022) -
α5 integrin regulates hepatic tight junctions through SRC-TET1-mediated DNA hydroxymethylation
por: Ma, Yuejiao, et al.
Publicado: (2022)